← All companies

CVKD

Cadrenal Therapeutics, Inc.

CVKD Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.96

-0.13 -6.22%

Key statistics

from XBRL data in SEC filings

Market cap

$5.62M

Revenue (TTM)

—

Net income (TTM)

-$11.9M

EPS (TTM)

$-5.59

P/E ratio

—

Dividend yield

841.84%

Free cash flow

-$12.6M

Cash

$2.31M

Total assets

$2.86M

Gross margin

—

52-week range

$1.86 – $14.64

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jul 21, 2026 8-K Director or officer change Jul 17, 2026 8-K Director or officer change Jul 10, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 1, 2026 8-K Director or officer change Jun 29, 2026 8-K Regulation FD disclosure; Other events Jun 18, 2026 8-K Director or officer change Jun 3, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Regulation FD disclosure; Other events Apr 30, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Regulation FD disclosure; Other events Mar 12, 2026 8-K Other events Feb 24, 2026 8-K Other events Dec 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 16, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Dec 11, 2025 8-K Director or officer change; Other events Dec 1, 2025 8-K Other events Nov 18, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Shareholder vote results Sep 24, 2025 8-K Entered a material agreement; Regulation FD disclosure; Other events Sep 15, 2025 8-K Results of operations (earnings release) Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Other events Aug 5, 2025 8-K Director or officer change; Item 5.08; Other events Jul 18, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Other events Apr 17, 2025 8-K Results of operations (earnings release) Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Entered a material agreement; Other events Mar 4, 2025 8-K Director or officer change; Other events Feb 7, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Other events Nov 4, 2024 8-K Regulation FD disclosure; Other events Oct 24, 2024 8-K Regulation FD disclosure; Other events Sep 25, 2024